IGF::OT::IGF IMMUNOGENICITY OF NONAVALENT HPV VACCINE ADMINISTERED PRIOR TO LIVING DONOR RENAL TRANSPLANTATION IN ADULT WOMEN: A PROSPECTIVE, SINGLE-ARM, MULTI-CENTER CLINICAL TRIAL

NIH RePORTER · NIH · N01 · $31,613 · view on reporter.nih.gov ↗

Abstract

The contractor will conduct a prospective single-arm trial to evaluate if the nonavalent HPV Gardasil 9 HPV vaccine induces and sustains an adequate immune response at 12-months post-transplantation among 18-49 years old female living donor kidney transplant recipients when ≥ 1 doses of the vaccine are administered ≥ 30 days prior to transplantation.

Key facts

NIH application ID
10487381
Project number
261201200035I-P00002-26100010-1
Recipient
NORTHWESTERN UNIVERSITY
Principal Investigator
SEEMA KHAN
Activity code
N01
Funding institute
NIH
Fiscal year
2021
Award amount
$31,613
Award type
—
Project period
2016-09-15 → 2023-09-14